Medical Technology, Devices and Diagnostics Industry Capability Report
Download The Report
Australia’s medical technology sector is a critical pillar of the nation’s health system, advanced manufacturing capability and export economy.
The Medical Technology, Devices and Diagnostics Industry Capability Report, co-authored by the Medical Technology Association of Australia (MTAA) and the Australian Trade and Investment Commission (Austrade), provides a comprehensive overview of Australia’s MedTech strengths and global competitiveness.
Australian MedTech supports the prevention, diagnosis, treatment and management of disease and disability through a diverse range of technologies, from implantable devices and diagnostics to robotics, precision engineering and software-based solutions including artificial intelligence and digital health.
Australia’s capability is underpinned by:
- A highly skilled STEM workforce and strong research base
- Over 850 MedTech companies generating significant export revenue
- Globally recognised regulatory standards through the Therapeutic Goods Administration (TGA)
- Advanced manufacturing and precision engineering capability
- Strong intellectual property protections and R&D incentives
- Established clinical trial infrastructure supporting early validation and commercialisation
The report outlines:
- An overview of Australia’s MedTech ecosystem and global market position
- Key industry strengths and competitive advantages
- Manufacturing and supply chain capability
- The regulatory and commercialisation landscape
- Investment and capital environment
- Strategic growth opportunities across North America, Europe and the Asia-Pacific region
- Case studies highlighting leading Australian MedTech innovators
Australia has a long history of globally transformative innovation, from the cochlear implant and CPAP technology to AI-enabled diagnostics and 3D-printed implants, and continues to lead in emerging fields including Software-as-a-Medical-Device (SaMD), robotics and precision medicine.
This report positions Australia as a trusted, innovation-driven MedTech partner and reinforces the country’s role as a strategic gateway into fast-growing healthcare markets across the Asia-Pacific and GCC regions, as well as established North American and European markets.
